Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea
- 1 November 2001
- journal article
- case report
- Published by Springer Science and Business Media LLC in Investigational New Drugs
- Vol. 19 (4), 341-343
- https://doi.org/10.1023/a:1010678214152
Abstract
Purpose. Severe diarrhea can represent adose-limiting toxicity with the use ofCPT-11. Conventional therapy isineffective in some patients and is alsolimited by patient compliance. We reportour observation on the effectiveness ofoctreotide acetate in the treatment ofCPT-11-induced diarrhea refractory toopioids. Patients and methods. We describe 4 patientswith metastaticgastrointestinal tumors who developedsevere diarrhea following treatment withCPT-11 (65–125 mg/m2/weekly for 4weeks every 6 weeks). Diarrhea wasrefractory to treatment with loperamide anddiphenoxylate and was treated withoctreotide acetate. Results. Complete resolution ofdiarrhea was observed within 2–4 days of octreotideacetate treatment. Three patientsresponded to SC octreotide given every 8hours and the 4th patient tooctreotide given by continuous SC infusion.Conclusions. Our preliminary observation suggestsvalue of octreotide in the control of CPT-11induced refractory diarrhea. Prospectivestudies are warranted.Keywords
This publication has 10 references indexed in Scilit:
- Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.Journal of Clinical Oncology, 1998
- Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.Journal of Clinical Oncology, 1995
- Control of Chemotherapy-Induced Diarrhea with OctreotideOncology, 1994
- Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinomaCancer, 1993
- Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapyAnti-Cancer Drugs, 1993
- Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.Journal of Clinical Oncology, 1993
- A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1987